Author

Thiago Favano

Observed names: T Favano, T. Favano

Institution: MiNK Therapeutics (United States)

Observed institutions: Universidade de São Paulo, Agenus (United States), MiNK Therapeutics (United States)

ORCID: 0000-0002-3927-2025

Observed ORCID: 0000-0002-3927-2025

OpenAlex ID: A5107565642

Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor

2025 · Benjamin Garmezy, Joseph E. Grossman, et al. · Oncogene · 10

10-Year Real-World Data on Acute Myeloid Leukemia: The Paradigm of a Public Health Center in Brazil

2024 · Camilla Campos, Alini Maria Orathes Ponte Silva, et al. · JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY · 2

Persistent SARS-CoV-2 Viremia, COVID-19 Associated Acute Respiratory Distress Syndrome, Severe Coagulopathy and Massive Hemoptysis in a Renal Transplant Patient on Veno-Venous Extracorporeal Membrane Oxygenation

2024 · T.C. Hammond, C.L. Channick, et al. · American Journal of Respiratory and Critical Care Medicine · 2

Challenges in the integration of palliative care for patients with hematologic malignancies: an analysis of the surprise question in a prospective cohort study

2025 · Alini Maria Orathes Ponte Silva, Diego Lopes Paim Miranda, et al. · Sao Paulo Medical Journal · 1

D107-03 Novel Interleukin-15 Superagonist (n-803) and Invariant Natural Killer T Cell (agent-797) Combination Immunotherapy for Unresolving Coccidioides Immitis Infection

2026 · T C Hammond, M Purbhoo, et al. · American Journal of Respiratory and Critical Care Medicine

Rapid suppression of unresolving disseminated coccidioidomycosis infection with combined IL-15 super-agonist (N-803) and invariant natural killer T cell therapy

2026 · Terese C. Hammond, Marco A Purbhoo, et al. · Clinical Immunology Communications

1344 AgenT-797, an allogeneic iNKT cell therapy, demonstrates durable clinical activity in solid tumors: updated phase 1 findings

2025 · Marco A Purbhoo, Thiago Favano, et al. · Journal for ImmunoTherapy of Cancer

Cuidados paliativos para pacientes com neoplasias hematológicas: “muito tarde, muito pouco”

2024 · Alini Maria Orathes Ponte Silva, Marco Aurelio Salvino, et al. · Caderno Pedagógico

Challenges to achieving BMT in the treatment of AML in Brazil: Bahia University Hematology Center experience

2023 · Felipe Feistauer, Marco Salvino, et al. · JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY

Works count: 9

Citation count: 15

H-index: 2

I10-index: 1